Vertex Pharmaceuticals (VRTX) Earnings Date, Estimates & Call Transcripts $446.15 -4.35 (-0.97%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$449.28 +3.13 (+0.70%) As of 06/9/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vertex Pharmaceuticals Earnings Summary Vertex Pharmaceuticals released Q1 2025 earnings on May 5, 2025, reporting an EPS of $4.06, which missed the consensus estimate of $4.29 by $0.23. Quarterly revenue rose 2.6% year-over-year to $2.77 billion, below analyst estimates of $2.85 billion. With a trailing EPS of -$3.92, Vertex Pharmaceuticals' earnings are expected to grow 12.03% next year, from $15.63 to $17.51 per share. Upcoming Q2 Earnings DateJul. 30After Market ClosesEstimatedConsensus EPS (May. 5) $4.29 Actual EPS (May. 5) $4.06 Missed By -$0.23 Actual Revenue (May. 5) $2.77BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)VRTX Upcoming EarningsVertex Pharmaceuticals' next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Vertex Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vertex Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVRTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Vertex Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20252$3.50$3.61$3.56Q2 20253$3.70$3.95$3.81Q3 20253$3.90$4.28$4.11Q4 20253$4.01$4.70$4.42 FY 2025 11 $15.11 $16.54 $15.90 Q1 20261$3.82$3.82$3.82Q2 20261$3.95$3.95$3.95Q3 20261$4.13$4.13$4.13Q4 20261$4.44$4.44$4.44 FY 2026 4 $16.34 $16.34 $16.34 Q1 20271$4.24$4.24$4.24 Vertex Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/5/2025Q1 2025$4.29$4.06 -$0.23$2.49$2.85B$2.77B2/10/2025Q4 2024$3.99$3.54 -$0.45$3.50$2.78B-11/4/2024Q3 2024$3.61$4.38+$0.77$4.07$2.69B$2.77B8/1/2024Q2 2024-$12.54-$12.83 -$0.29-$12.62$2.66B$2.65B5/6/2024Q1 2024$3.66$4.76+$1.10$4.37$2.58B$2.69B2/5/2024Q4 2023$3.85$4.20+$0.35$3.43$2.50B$2.52B11/6/2023Q3 2023$3.53$4.08+$0.55$3.37$2.50B$2.48B8/1/2023Q2 2023$3.47$3.53+$0.06$3.54$2.41B$2.49B Vertex Pharmaceuticals Earnings - Frequently Asked Questions When is Vertex Pharmaceuticals's earnings date? Vertex Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on VRTX's earnings history. What guidance has Vertex Pharmaceuticals issued on next quarter's earnings? Vertex Pharmaceuticals issued an update on its FY 2025 earnings guidance on Monday, May, 5th. The company issued revenue guidance of $11.9 billion-$12.0 billion, compared to the consensus revenue estimate of $12.0 billion. Did Vertex Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vertex Pharmaceuticals (NASDAQ:VRTX) missed the analysts' consensus estimate of $4.29 by $0.23 with a reported earnings per share (EPS) of $4.06. Learn more on analysts' earnings estimate vs. VRTX's actual earnings. How can I listen to Vertex Pharmaceuticals's earnings conference call? The conference call for Vertex Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Vertex Pharmaceuticals's conference call transcript? The conference call transcript for Vertex Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded annual revenue of $11.10 billion. How much profit does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded net income of -$535.60 million. VRTX has generated -$3.92 earnings per share over the last four quarters. What is Vertex Pharmaceuticals's price-to-earnings ratio? Vertex Pharmaceuticals (NASDAQ:VRTX) has a forward price-to-earnings ratio of 28.54. The price/earnings-to-growth ratio is 2.11. What is Vertex Pharmaceuticals's EPS forecast for next year? Vertex Pharmaceuticals's earnings are expected to grow from $15.63 per share to $17.51 per share in the next year, which is a 12.03% increase. More Earnings Resources from MarketBeat Related Companies AMGN Earnings Results GILD Earnings Results REGN Earnings Results ALNY Earnings Results BIIB Earnings Results UTHR Earnings Results INCY Earnings Results NBIX Earnings Results EXEL Earnings Results BMRN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:VRTX) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWall Street Legend: Crash coming in March—details hereBad News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history give...Chaikin Analytics | SponsoredTrump’s treachery A few months ago, I released a list of six companies I believed were going to appreciate under Trump’s second ...Porter & Company | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
